NEW YORK (GenomeWeb News) – NobleGen Biosciences has received a $182,000 Phase I SBIR grant from the National Human Genome Research Institute top optimize chemistry for its Optipore sequencing technology. The Concord, Mass.-based firm is developing a nanopore-based method for DNA sequencing by nanopore induced photon emission (SNIPE).